Company Information

FERMENTA BIOTECH LTD.

NSE : NABSE : 506414ISIN CODE : INE225B01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE183.250.25 (+0.14 %)
PREV CLOSE ( ) 183.00
OPEN PRICE ( ) 184.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11408
TODAY'S LOW / HIGH ( )181.00 186.05
52 WK LOW / HIGH ( ) 132.3214
NSE
This Company is not listed in NSE
ChairmanPradeep M Chandan
Managing DirectorPrashant Nagre
Company SecretarySrikant N Sharma
Executive DirectorSatish Varma
Anupama Datla Desai
Vice ChairmanKrishna Datla
Non Executive DirectorRajeshwari Datla
Non Executive Independent DirectorGopakumar Nair
Rajashri Ojha
Pramod Kasat
Incorporation Year : 1951

Registered Office :

Address : A 1501, Thane One,Dil Complex, Ghodbhunder Road,Majiwada Thane,
Maharashtra-400610 .

Phone : 022-67980888

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.